Institute of Cancer Research

The Institute of Cancer Research (the ICR) is a cancer research university located in London, United Kingdom and a constituent college of the federal University of London. It was founded in 1909 as a research department of the Royal Marsden Hospital and joined the University of London in 2003. It has been responsible for a number of breakthrough discoveries, including that the basic cause of cancer is damage to DNA. Together with the Royal Marsden Hospital the ICR forms the largest comprehensive cancer centre in Europe, and was ranked first amongst all British higher education institutions in the Times Higher Education 2008 Research Assessment Exercise Table of Excellence. In addition to its research activities the ICR provides both taught postgraduate degree programmes and research degrees and currently has around 340 students. It occupies two sites, one in Chelsea in Central London and one in Sutton in southwest London, and had a total income of £85.4 million in 2010/11, of which £50.5 million was from research grants and contracts.


Some content from Wikipedia, licensed under CC BY-SA

Whole-genome scan helps select best treatment for childhood cancer

A whole-genome scan to identify large-scale chromosomal damage can help doctors choose the best treatment option for children with neuroblastoma, one of the most common types of childhood cancer, finds an international collaboration ...

Cancer created Sep 14, 2012 | popularity 5 / 5 (1) | comments 0 | with audio podcast

Golden age of prostate cancer treatment hailed as fourth drug in two years extends life

The head of one of the UK's leading cancer research organisations has hailed a golden age in prostate cancer drug discovery as for the fourth time in two years results are published finding a new drug can significantly extend ...

Cancer created Aug 15, 2012 | popularity 1 / 5 (1) | comments 1 | with audio podcast

Lower risk of serious side-effects in trials of new targeted drugs

Patients in early clinical trials of new-style targeted cancer therapies appear to have a much lower risk of the most serious side-effects than with traditional chemotherapy, according to a new analysis.

Cancer created Aug 07, 2012 | popularity not rated yet | comments 0

Obesity may affect response to breast cancer treatment: study

Women who are obese continue to have higher levels of oestrogen than women of normal weight even after treatment with hormone-suppressing drugs, raising the possibility that they might benefit from changes to their treatment.

Cancer created Jul 16, 2012 | popularity not rated yet | comments 0 | with audio podcast

Scientists develop new strategy to overcome drug-resistant childhood cancer

A new drug combination could offer hope to children with neuroblastoma – one of the deadliest forms of childhood cancer – by boosting the effectiveness of a promising new gene-targeted treatment.

Cancer created Jul 11, 2012 | popularity 5 / 5 (1) | comments 0 | with audio podcast